H. Jung

发表

Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice

Sunghoon Kim, Zihai Li, J. Y. Lee, 2010, PloS one.

Identification of a novel SIRT7 inhibitor as anticancer drug candidate.

Jong-Hoon Kim, Ji-Hye Kim, H. Jung, 2019, Biochemical and biophysical research communications.

KRC-327, a selective novel inhibitor of c-Met receptor tyrosine kinase with anticancer activity.

H. Jung, Soon-Sun Hong, K. Jung, 2013, Cancer letters.

Design and Synthesis of Novel Pyrazolo[3,4‐d]pyrimidin‐1‐yl piperidine Derivatives as Bruton's Tyrosine Kinase Inhibitors

Jeong Hee Jeon, Chi-Hoon Park, H. Jung, 2017 .

Neuron-Specific Fluorescence Reporter-Based Live Cell Tracing for Transdifferentiation of Mesenchymal Stem Cells into Neurons by Chemical Compound

Hyun Woo Kwon, D. Hwang, D. S. Lee, 2017, Stem cells international.

Discovery of a new and efficient small molecule for neuronal differentiation from mesenchymal stem cell.

Sung Soo Kim, H. Jung, Sang-Un Choi, 2009, Journal of medicinal chemistry.

Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors.

N. Kang, H. Jung, Sun-Young Han, 2010, Bioorganic & medicinal chemistry letters.

Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.

H. Jung, Sun-Young Han, J. Ha, 2012, Bioorganic & medicinal chemistry letters.

Design and Synthesis of Novel 3-(2-Aminopyridin-3-yl)-1,2,4-Triazolo[4,3-b ]Pyridazine Derivatives as a Reversible Bruton's Tyrosine Kinase Inhibitors

Jeong Hee Jeon, Chi-Hoon Park, H. Jung, 2018, Bulletin of the Korean Chemical Society.

Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors

Byung Jin Byun, Eun-Young Kim, Chi-Hoon Park, 2016, Archives of pharmacal research.

Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities

Chi-Hoon Park, H. Jung, C. Yun, 2014, Archives of pharmacal research.

Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment.

Chi-Hoon Park, H. Jung, C. Yun, 2013, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationship of aminopyridines with substituted benzoxazoles as c-Met kinase inhibitors.

Chi-Hoon Park, H. Jung, Sang-Un Choi, 2012, Bioorganic & medicinal chemistry letters.

Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors

Chi-Hoon Park, H. Jung, C. Yun, 2016, Archives of Pharmacal Research.

Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors.

Eun-Young Kim, Chi-Hoon Park, H. Jung, 2014, Bioorganic & medicinal chemistry letters.

Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo

H. Jung, Mi-Ok Lee, H. Cha, 2012, Investigational New Drugs.

Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins.

H. Jeong, Chi-Hoon Park, H. Jung, 2015, Biochemical and biophysical research communications.

Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors.

N. Kang, H. Jung, Sang-Un Choi, 2011, Bioorganic & medicinal chemistry letters.

Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer.

H. Jeong, Eun-Young Kim, Sunjoo Ahn, 2016, Cancer letters.

Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells

Hyung Rae Kim, Chi-Hoon Park, H. Jung, 2016, BMC Cancer.

Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R.

Sunjoo Ahn, Chi-Hoon Park, H. Jung, 2017, European journal of medicinal chemistry.

Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing bicyclic aminobenzazepines for anaplastic lymphoma kinase (ALK) inhibitor.

Sunjoo Ahn, Chi-Hoon Park, Minji Lee, 2015, Bioorganic & medicinal chemistry letters.

Loss-of-SIRT7 sensitizes hepatocellular carcinoma to sorafenib through the regulation of ERK Phosphorylation

J. Auwerx, D. Ryu, M. Shong, 2023, bioRxiv.

Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors.

H. Seo, H. Jung, C. Yun, 2013, Bioorganic & medicinal chemistry letters.

Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities

Chi-Hoon Park, H. Jung, C. Yun, 2013, Archives of Pharmacal Research.

Design, Synthesis, and Evaluation of 2,4‐Di(piperidine‐substituted‐anilino)pyrimidine Derivatives as ALK Inhibitors

Sunjoo Ahn, Chi-Hoon Park, H. Jung, 2015 .

Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.

H. Jung, Sun-Young Han, J. Ha, 2012, Bioorganic & medicinal chemistry letters.

Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors.

Joo Yun Lee, Sunjoo Ahn, H. Jung, 2016, Bioorganic & medicinal chemistry.